Latest papers

Screening for Cardiac Risk Before Anthracycline Administration: What Are The Real Benefits?

Predicting the Likelihood of Nonsentinel Lymph Node Metastases in Triple Negative Breast Cancer Patients With a Positive Sentinel Lymph Node: Turkish Federation of Breast Disease Associations Protocol MF09-01

A case of late breast cancer metastases to both suprarenal glands 28 years after mastectomy.

Response to "Timing of radiotherapy and outcome in patients receiving adjuvant endocrine therapy." (Int J Radiat Oncol Biol Phys 2011;80:398-402).

Patient-centered care model demands better physician-patient communication.

The challenge of developing quality measures for breast cancer surgery.

Variability in reexcision following breast conservation surgery.

Pleomorphic Lobular Carcinoma in Situ: Treatment Options for a New Pathologic Entity

Comparative Acute Toxicity from Whole Breast Irradiation Using 3-Week Accelerated Schedule With Concomitant Boost and the 6.5-Week Conventional Schedule With Sequential Boost for Early-Stage Breast Cancer

Trastuzumab Treatment in Multiple Lines: Current Data and Future Directions

Routine cardiac evaluation in patients with early-stage breast cancer before adjuvant chemotherapy.

A case of late breast cancer metastases to both suprarenal glands 28 years after mastectomy.

Differential effect of the expression of TGF-β pathway inhibitors, Smad-7 and Ski, on invasive breast carcinomas: relation to biologic behavior.

First-line endocrine therapy alone could be a reasonable treatment option for hormone-positive, HER2-positive metastatic breast cancer.

Beta-adrenergic blockers and breast cancer.

Do the benefits of screening mammography outweigh the harms of overdiagnosis and unnecessary treatment?--yes.

Clinical trials. Experimental cancer therapies move to the front line.

Cancer. Taking a back door to target Myc.

Do the benefits of screening mammography outweigh the harms of overdiagnosis and unnecessary treatment?--no.

Pertuzumab plus trastuzumab plus docetaxel for metastatic breast cancer.